Our Science
Disease Area
- Multiple
Modality
- Multiple
Disease Area
- Multiple
Modality
- Multiple
By: Dr. Alison Betts, Vice President of Scientific Collaborations and Fellow of Modeling & Simulation of Applied BioMath
Disease Area
- Oncology
- Immuno-oncology
Modality
- Multiple

Collaboration with Antengene - Presented at SITC 2021
Disease Area
- Oncology
Modality
- Bispecific
Published in Pharma Tech Outlook Magazine
Disease Area
- Multiple
Modality
- Bispecific
- mAb

Collaboration with Astellas Pharma - Published in CPT: Pharmacometrics & Systems Pharmacology
Disease Area
- Oncology
Modality
- Small Molecule

Collaboration with CytomX Therapeutics - Published in Clinical Pharmacology & Therapeutics
Disease Area
- Oncology
Modality
- mAb

Collaboration with Jounce - Presented at ASCO Annual Meeting 2017
Disease Area
- Oncology
Modality
- mAb
Published in Clinical Pharmacology & Therapeutics
Disease Area
- Oncology
Modality
- Bispecific

Collaboration with Pfizer - Presented by Alison Betts, Applied BioMath
Disease Area
- Oncology
Modality
- Bispecific
Published in AAPS Newsmagazine
Disease Area
- Multiple
Modality
- Multiple
Best Poster Award at World ADC 2016
Disease Area
- Oncology
Modality
- ADC